The use of digital health technologies across healthcare and drug development has accelerated. A new paper in the Journal of Parkinson’s Disease titled “Digital Progression Biomarkers as Novel Endpoints in […]
In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices, and re-purposed drugs are urgently needed. Randomized clinical trials are used to provide evidence of safety […]
The U.S. Food and Drug Administration just issued a call for applications for the next cohort of the Patient Engagement Collaborative (PEC). The PEC, established in 2018 in collaboration with […]
Researchers are using computer models to simulate COVID-19 infections on a cellular level—the basic structural level of the human body. The models allow for virtual trials of drugs and vaccines, […]
“Conflict isn’t always bad,” says Dr. Kelly Willenberg, DBA, RN, CCRP, CHC, CHRC, manager of Kelly Willenberg & Associates. She’s a big proponent of what she calls “conflict competence,” or […]